Coordinate regulation of Phase I and II xenobiotic metabolisms by the Ah receptor and Nrf2

Biochemical Pharmacology

Volumn 73, Issue 12, 2007, Pages 1853-1862

  Köhle, Christoph ^a   Bock, Karl Walter ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Ah receptor; Benzo a pyrene quinones; Coordinate induction; Nrf2, Phase I and II metabolism; Response elements

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; BENZO[A]PYRENE; CATECHOL ESTROGEN; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; DIOXIN; GLUCURONOSYLTRANSFERASE 1A1; GLUCURONOSYLTRANSFERASE 1A6; GLUTATHIONE TRANSFERASE A2; QUINONE DERIVATIVE; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR NRF2; XENOBIOTIC AGENT;

ARTICLE; BILE; DETOXIFICATION; DNA RESPONSIVE ELEMENT; ELECTROPHILIC STRESS; ENZYME REGULATION; GENE TARGETING; GENETIC LINKAGE; GENETIC POLYMORPHISM; HUMAN; METABOLIC REGULATION; METABOLITE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; RISK ASSESSMENT; SIGNAL TRANSDUCTION; TRANSGENIC ANIMAL; URINARY EXCRETION; URINE; XENOBIOTIC METABOLISM;

EID: 34247603065     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2007.01.009     Document Type: Note

References (96)

1. Poland A., and Knutson J.C. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Ann Rev Pharmacol Toxicol 22 (1982) 517-554
2. Gu Y.Z., Hogenesch J.B., and Bradfield C.A. The PAS superfamily: sensors of environmental and developmental signals. Ann Rev Pharmacol Toxicol 40 (2000) 519-561
3. Bock K.W., and Köhle C. Ah receptor: dioxin-mediated toxic responses as hints to deregulated physiologic functions. Biochem Pharmacol 72 (2006) 393-404
4. Nebert D.W., and Gonzalez F.J. P450 genes: structure, evolution, and regulation. Ann Rev Biochem 56 (1987) 945-993
5. Nebert D.W., Roe A.L., Dieter M.Z., Solis W.A., Yang Y., and Dalton T.P. Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochem Pharmacol 59 (2000) 65-85
6. Whitlock J.P. Induction of cytochrome P4501A1. Ann Rev Pharmacol Toxicol 39 (1999) 103-125
7. Hankinson O. The aryl hydrocarbon receptor complex. Ann Rev Pharmacol Toxicol 35 (1995) 307-340
8. Tijet N., Boutros P.C., Moffat I.D., Okey A.B., Tuomisto J., and Pohjanvirta R. Aryl hydrocarbon receptor regulates distinct dioxin-dependent and dioxin-independent gene batteries. Mol Pharmacol 69 (2006) 140-153
9. Maher J.M., Cheng X., Slitt A.L., Dieter M.Z., and Klaassen C.D. Induction of multidrug resistance-associated protein family of transporters by chemical activators of receptor-mediated pathways in mouse liver. Drug Metab Dispos 33 (2005) 956-962
10. Ramos-Gomez M., Kwak M.K., Dolan P.M., Itoh K., Yamamoto M., Talalay P., et al. Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc Natl Acad Sci USA 98 (2001) 3410-3415
11. Gao X., Dinkova-Kostova A.T., and Talalay P. Powerful and prolonged protection of human retinal pigment epithelial cells against oxidative damage: the indirect oxidant effects of sulforaphane. Proc Natl Acad Sci USA 98 (2001) 15221-15226
12. Thimmulappa R.K., Mai K.H., Srisuma S., Kensler T.W., Yamamoto M., and Biswal S. Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res 62 (2002) 5196-5203
13. Nguen T., Sherratt P.J., and Pickett C.B. Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Ann Rev Pharmacol Toxicol 43 (2003) 233-260
14. Ma G., Kinneer K., Bi Y., Chan J.Y., and Kan Y.W. Induction of murine NAD(P)H:quinone oxidoreductase by 2,3,7,8-tetrachlorodibenzo-p-dioxin requires CNC (cap 'n' collar) basic leucine zipper factor Nrf2 (nuclear factor erythroid 2-related factor 2): cross-interaction between AhR (aryl hydrocarbon receptor) and Nrf2 signal transduction. Biochem J 377 (2004) 204-213
15. Köhle C., and Bock K.W. Activation of coupled Ah receptor and Nrf2 gene batteries by dietary phytochemicals in relation to chemoprevention. Biochem Pharmacol 72 (2006) 795-805
16. Erickson A.M., Nevarea Z., Gipp J.J., and Mulcahy R.T. Identification of a variant antioxidant response element in the promoter of the human glutamate-cysteine ligase modifier subunit gene. J Biol Chem 277 (2002) 30730-30737
17. Nioi P., McMahon M., Itoh K., Yamamoto M., and Hayes J.D. Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence. Biochem J (2003) 337-348
18. Leung L., Kwong M., Hou S., Lee C., and Chan J.Y. Deficiency of the Nrf1 and Nrf2 transcription factors results in early embryonic lethality and severe oxidative stress. J Biol Chem 278 (2003) 48021-48029
19. An J.H., Vranas K., Louke M., Inouie H., Hisamoto N., Matsumoto K., et al. Regulation of the Caenorrhabditis elegans oxidative stress defense protein SKN-1 by glycogen synthase kinase 3. Proc Natl Acad Sci USA 102 (2005) 16275-16280
20. Miao W., Hu L., Scrivens J., and Batist G. Transcriptional regulation of NF-E2 p45-related factor (Nrf2) expression by the aryl hydrocarbon receptor-xenobiotic response element signaling pathway. J Biol Chem 280 (2005) 20340-20348
21. Nebert D.W., Dalton T.P., Okey A.B., and Gonzalez F.J. Role of aryl hydrocarbon receptor-mediated induction of CYP1 enzymes in environmental toxicity and cancer. J Biol Chem 279 (2004) 23847-23850
22. Denison M.S., Fisher J.M., and Whitlock J.P. The DNA recognition site for the dioxin-Ah receptor complex. J Biol Chem 263 (1988) 17221-17224
23. Fujisawa-Sehara A., Yamane M., and Fujii-Kuriyama Y. A DNA-binding factor specific for xenobiotic response elements of P-450c gene exists as a cryptic form in cytoplasma: its possible translocation to nucleus. Proc Natl Acad Sci USA 65 (1998) 5859-5863
24. Swanson H.I., and Bradfield C.A. The Ah-receptor: genetics, structure and function. Pharmacogenetics 3 (1993) 213-230
25. Kress S., Reichart J., and Schwarz M. Functional analysis of the human cytochrome P4501A1 (CYP1A1) gene enhancer. Eur J Biochem 258 (1998) 803-812
26. Ueda R., Iketaki H., Nagata K., Kimura S., Gonzalez F.J., Kusano K., et al. A common regulatory region functions bidirectionally in transcriptional activation of the human CYP1A1 and CYP1A2 genes. Mol Pharmacol 69 (2006) 1924-1930
27. Eaton D.L., Gallagher E.P., Bammler T.K., and Kunze K.L. Role of cytochrome P4501A2 in chemical carcinogenesis: implications for human variability in expression and enzyme activity. Pharmacogenetics 5 (1995) 259-274
28. Bock K.W., Schrenk D., Forster A., Griese E.U., Mörike K., Brockmeier D., et al. The influence of environmental and genetic factors on CYP2D6, CYP1A2 and UDP-glucuronosyltransferases in man using sparteine, caffeine, and paracetamol as probes. Pharmacogenetics 4 (1994) 209-218
29. Quattrochi L.C., Vu T., and Tukey R.H. The human CYP1A2 gene and induction by 3-methylcholanthrene. J Biol Chem 269 (1994) 6949-6954
30. Tang Y.M., Wo Y.Y.P., Stewart J., Hawkins A.L., Griffin C.A., Sutter T.R., et al. Isolation and characterization of the human cytochrome P450 CYP1B1 gene. J Biol Chem 271 (1996) 28324-28330
31. Zhang L., Zheng W., and Jefcoate C.R. Ah receptor regulation of mouse Cyp1B1 is additionally modulated by a second novel complex that forms at two AhR response elements. Toxicol Appl Pharmacol 192 (2003) 174-190
32. Eaton D.L., and Bammler T.K. Concise review of the glutathione S-transferases and their significance to toxicology. Toxicol Sci 49 (1999) 156-164
33. Hayes J.D., Flanagan J.U., and Jowsey I.R. Glutathione transferases. Ann Rev Pharmacol Toxicol 45 (2005) 51-88
34. Poulson K.E., Darnell J.E., Rushmore T., and Pickett C.B. Analysis of the upstream elements of the xenobiotic compound-inducible and positionally regulated glutathione S-transferase Ya gene. Mol Cell Biol 10 (1999) 1841-1852
35. Morel F., Rauch C., Coles B., LeFerrec E., and Guillouzo A. The human glutathione transferase alpha locus: genomic organization of the gene cluster and functional characterization of the genetic polymorphisms in the hGSTA1 promoter. Pharmacogenetics 12 (2002) 277-286
36. Mackenzie P.I., Owens I.S., Burchell B., Bock K.W., Bairoch A., Belanger A., et al. The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 7 (1997) 255-269
37. Tukey R.H., and Strassburg C.P. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Ann Rev Pharmacol Toxicol 40 (2000) 551-616
38. Mackenzie P.I., Bock K.W., Burchell B., Guillemette C., Ikushiro S., Iyanagi T., et al. Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genomics 15 (2005) 677-685
39. Chen S., Beaton D., Nguyen N., Senekeo-Effenberger K., Brace-Sinnokrak, Argikar U., et al. Tissue-specific, inducible, and hormonal control of the human UDP-glucuronosyltransferase-1 (UGT1) locus. J Biol Chem 280 (2005) 37547-37557
40. Ross D. Quinone reductases multitasking in the metabolic world. Drug Metab Rev 36 (2004) 639-654
41. Favreau L.V., and Pickett C.B. Transcriptional regulation of the rat NAD(P)H:quinone reductase gene. J Biol Chem 266 (1991) 4556-4561
42. Radjendirane V., and Jaiswal A.K. Antioxidant response element-mediated 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induction of human NADP(H):quinone oxidoreductase 1 gene expression. Biochem Pharmacol 58 (1999) 1649-1655
43. Marchand A., Barouki R., and Garlatti M. Regulation of NAD(P)H:quinone oxidoreductase 1 gene expression by CYP1A1 activity. Mol Pharmacol 65 (2004) 1029-1037
44. Morel F., Fardel O., Meyer D.J., Langouet S., Gilmore K.S., Meunier B., et al. Preferential increase of glutathione S-transferase class alpha transcripts in cultured human hepatocytes by phenobarbital, 3-methylcholanthrene, and ditiolethiones. Cancer Res 53 (1993) 2231-2234
45. Schrenk D., Stüven T., Gohl G., Viebahn R., and Bock K.W. Induction of CYP1A and glutathione S-transferase activities by 2,3,7,8-tetrachlorodibenzo-p-dioxin in human hepatocyte cultures. Cacinogenesis 16 (1995) 943-946
46. Malik N., and Owens I.S. Genetic regulation of bilirubin-UDP-glucuronosyltransferase induction by polycyclic aromatic compounds and phenobarbital in mice. J Biol Chem 256 (1981) 9599-9604
47. Yueh M.F., Huang Y.H., Hiller A., Chen S., Nguyen N., and Tukey R.H. Involvement of the xenobiotic response element (XRE) in Ah receptor-mediated induction of human UDP-glucuronosyltransferase 1A1. J Biol Chem 276 (2003) 15001-15006
48. Sugatani J., Sueyoshi T., Negishi M., and Miva M. Regulation of human UGT1A1 gene by nuclear receptors constitutive active/androstane receptor, pregnane X receptor, and glucocorticoid receptor. Meth Enzymol 400 (2005) 92-104
49. Köhle C., Badary O.A., Nill K., Bock-Hennig B.S., and Bock K.W. Serotonin glucuronidation by Ah receptor- and oxidative stress-inducible human UDP-glucuronosyltransferase (UGT) 1A6 in Caco-2 cells. Biochem Pharmacol 69 (2005) 1397-1402
50. Bock K.W., and Köhle C. UDP-glucuronosyltransferase 1A6: structural, functional, and regulatory aspects. Meth Enzymol 400 (2005) 57-75
51. Fernandez-Salguero P., Pineau T., Hilbert D.M., McPhail T., Lee S.S.T., Kimura S., et al. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science 268 (1995) 722-726
52. Emi Y., Ikushiro S., and Iyanagi T. Xenobiotic responsive element-mediated transcriptional activation in the UDP-glucuronosyltransferase family 1 gene complex. J Biol Chem 271 (1996) 3952-3958
53. Metz R.P., and Ritter J.K. Transcriptional activation of the UDP-glucuronosyltransferase 1A7 gene in rat liver by aryl hydrocarbon receptor ligands and oltipraz. J Biol Chem 273 (1998) 5607-5614
54. Münzel P.A., Schmohl S., Buckler F., Jaehrling J., Raschko F.T., Köhle C., et al. Contribution of the Ah receptor to phenolic antioxidant-mediated expression of human and rat UDP-glucuronosyltransferase UGT1A6 in Caco-2 and rat hepatoma 5 L cells. Biochem Pharmacol 66 (2003) 841-847
55. Iida K., Itoh K., Kumagai Y., Oyasu R., Hattori K., Kawai K., et al. Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis. Cancer Res 64 (2004) 6424-6431
56. Soars M.G., Petullo D.M., Eckstein J.A., Kasper S.C., and Wrighton S.A. An assessment of UDP-glucuronosyltransferase induction using primary human hepatocytes. Drug Metab Dispos 32 (2004) 140-148
57. Ramos K.S. Redox regulation of c-Ha-ras and osteopontin signaling in vascular smooth muscle cells: implications in chemical atherogenesis. Ann Rev Pharmacol Toxicol 39 (1999) 243-265
58. Xiao G.H., Rinaire J.A., Rodrigues A.D., and Prough R.A. Regulation of the Ah gene battery via Ah receptor-dependent and independent processes in cultured adult rat hepatocytes. Drug Metab Dispos 23 (1995) 642-650
59. Jemnitz K., Veres Z., and Vereczkey L. Coordinate regulation of UDP-glucuronosyltransferase UGT1A6 induction by 3-methylcholanthrene and multidrug resistance protein MRP2 expression by dexamethasone in primary rat hepatocytes. Biochem Pharmacol 63 (2002) 2137-2144
60. Uno S., Dalton T.P., Dragin N., Curran C.P., Derkenne S., Miller M.L., et al. Oral benzo[a]pyrene in Cyp1 knockout mouse lines: CYP1A1 important in detoxication, CYP1B1 metabolism required for immune damage independent of body burden and clearance rate. Mol Pharmacol 69 (2006) 1103-1114
61. Zheng Z., Fang J.L., and Lazarus P. Glucuronidation: an important mechanism for detoxification of benzo[a]pyrene metabolites in aerodigestive tract tissue. Drug Metab Dispos 30 (2002) 397-403
62. Zheng Z., Park J.Y., Guillemette C., Schantz S.P., and Lazarus P. Tobacco carcinogen-detoxifying enzyme UGT1A7 and its association with orolaryngeal cancer risk. J Natl Cancer Inst 93 (2001) 1411-1418
63. Gregory P.A., Lewinski R.H., Gardner-Stephen D.A., and Mackenzie P.I. Regulation of UDP glucuronosyltransferases in the gastrointestinal tract. Toxicol Appl Pharmacol 199 (2004) 354-363
64. Hailfinger S., Jaworski M., Braeuning A., Buchmann A., and Schwarz M. Zonal expression in murine liver: lessons from tumors. Hepatology 43 (2006) 407-414
65. Lindros K.O., Oinonen T., Johansson I., and Ingelman-Sundberg M. Selective centrilobular expression of the aryl hydrocarbon receptor in rat liver. J Pharmacol Exp Ther 280 (1997) 506-511
66. Ullrich D., Fischer G., Katz N., and Bock K.W. Intralobular distribution of UDP-glucuronosyltransferase in livers from untreated, 3-methylcholathrene- and phenobarbital-treated rats. Chem Biol Interact 48 (1984) 181-190
67. Denison M.S., and Nagy S.R. Activation of aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Ann Rev Pharmacol Toxicol 43 (2003) 309-334
68. Rannug A., and Fritsche E. The aryl hydrocarbon receptor and light. Biol Chem 387 (2006) 1149-1157
69. Lilienblum W., Irmscher G., Fusenig N.E., and Bock K.W. Induction of UDP-glucuronosyltransferase and aryl hydrocarbon hydroxylase activity in mouse skin and normal and transformed skin cells in culture. Biochem Pharmacol 35 (1986) 1517-1520
70. Miller E.C., and Miller J.A. Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules. Cancer 47 (1981) 2327-2345
71. Conney A.H. Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: C. H. A. Clowes memorial lecture. Cancer Res 42 (1982) 4875-4917
72. Miller K.P., and Ramos K.S. Impact of cellular metabolism on the biological effects of benzo[a]pyrene and related hydrocarbons. Drug Metab Rev 33 (2001) 1-35
73. Hu Z., and Wells P.G. In vitro and in vivo biotransformation and covalent binding of benzo[a]pyrene in Gunn and RHA rats with a genetic deficiency in bilirubin uridine diphosphate-glucuronosyltransferase. J Pharmacol Exp Ther 263 (1992) 334-342
74. Hu Z., and Wells P.G. Human interindividual variation in lymphocyte UDP-glucuronosyltransferases as a determinant of in vitro benzo[a]pyrene covalent binding and cytotoxicity. Toxicol Sci 78 (2004) 32-40
75. Boroujerdi M., Kung H.C., Wilson A.G.E., Anderson M.W., and Metabolism. DNA binding of bezo[a]pyrene in vivo in the rat. Cancer Res 41 (1981) 951-957
76. Bevan D.R., and Sadler V.M. Quinol diglucuronides are predominant conjugated metabolites found in bile of rats following intratracheal instillation of benzo[a]pyrene. Carcinogenesis 13 (1992) 403-407
77. Yang Y., Griffiths W.J., Midtvedt T., Sjövall J., Rafter J., and Gustafsson J.A. Characterization of conjugated metabolites of benzo[a]pyrene in germ-free rat urine by liquid chromatography/electrospray tandem mass spectroscopy. Chem Res Toxicol 12 (1999) 1182-1189
78. Burdick A.D., Davis II J.W., Liu K.J., Hudson L.G., Shi H., Monske M.L., et al. Benzo(a)pyrene quinones increase cell proliferation, generate reactive oxygen species, and transactivate the epidermal growth factor receptor in breast epithelial cells. Cancer Res 63 (2003) 7825-7833
79. Lilienblum W., Bock-Hennig B.S., and Bock K.W. Protection against toxic redox cycles between benzo[a]pyrene-3,6-quinone and its quinol by 3-methylcholanthrene-inducible formation of the quinol mono- and diglucuronide. Mol Pharmacol 27 (1985) 451-458
80. Bock K.W., Gschaidmeier H., Seidel A., Baird S., and Burchell B. Mono- and diglucuronide formation from chrysene and benzo[a]pyrene phenols by 3-methylcholanthrene-inducible phenol UDP-glucuronosyltransferase (UGT1A1). Mol Pharmacol 42 (1992) 613-618
81. Bock K.W., Raschko F.T., Gschaidmeier H., Seidel A., Oesch F., Grove A.D., et al. Mono- and diglucuronide formation of benzo[a]pyrene and chrysene diphenols by AHH-1 cell expressed UDP-glucuronosyltransferase UGT1A7. Biochem Pharmacol 57 (1999) 653-656
82. Gschaidmeier H., Seidel A., Burchell B., and Bock K.W. Formation of mono- and diglucuronides and other glycosides of benzo[a]pyrene-3,6-quinol by V79 cell-expressed human phenol UDP-glucuronosyltransferases of the UGT1 gene complex. Biochem Pharmacol 49 (1995) 1601-1606
83. Bock K.W., Gschaidmeier H., Heel H., Lehmköster T., Münzel P.A., Raschko F., et al. Ah receptor-controlled transcriptional regulation of rat and human UDP-glucuronosyltransferase isoforms. Adv Enzyme Regul 38 (1998) 207-222
84. Gamage N., Barnett A., Hempel N., Duggleby R.G., Windmill K.F., Martin J.L., et al. Human sulfotransferases and their role in chemical metabolism. Toxicol Sci 90 (2006) 5-22
85. Sies H. Strategies of antioxidant defense. Eur J Biochem 215 (1993) 213-219
86. Zhu B.T., and Conney A.H. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 19 (1998) 1-27
87. Lier J.G., and Ricci M.J. 4-Hydroxylation of estrogens as marker of human mammary tumors. Proc Natl Acad Sci USA 93 (1996) 3294-3296
88. Michnovicz J.J., Hershcopf R.J., Naganuma H., Bradlow H.L., and Fishman J. Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. New Engl J Med 315 (1986) 1305-1309
89. Michnovicz J.J., and Bradlow H.L. Induction of estradiol metabolism by dietary indole-3-carbinol in humans. J Natl Cancer Inst 82 (1990) 947-949
90. Cheng Z., Rios G.R., King C.D., Coffman B.L., Green M.D., Mojarabbi B., et al. Glucuronidation of catechol estrogens by expressed human UDP-glucuronosyltransferases (UGTs) 1A1,1A3, and 2B7. Toxicol Sci 45 (1998) 52-57
91. Guillemette C., Millikan R.C., Newman B., and Housman D.E. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans. Cancer Res 60 (2000) 950-956
92. West J.D., and Marnett L.J. Endogenous reactive intermediates as modulators of cell signaling and cell death. Chem Res Toxicol 19 (2006) 173-194
93. Sun Y.V., Boverhof D.R., Burgoon L.D., Fielder M.R., and Zacharewski T.R. Comparative analysis of dioxin response elements in human, mouse and rat genomic sequences. Nucleic Acids Res 32 (2004) 4512-4523
94. Brigelius-Flohe R. Glutathione peroxidases and redox-regulated transcription factors. Biol Chem 387 (2006) 1329-1335
95. Keppler D. Uptake and efflux transporters for conjugates in human hepatocytes. Meth Enzymol 400 (2005) 531-542
96. Ebert B., Seidel A., and Lampen A. Identification of BCRP as transporter of benzo[a]pyrene conjugates metabolically formed in Caco-2 cells and its induction by Ah-receptor agonists. Carcinogenesis 26 (2005) 1754-1763